Perbedaan Diagnos Laboratorium Utama Tbk. dan Kian Santang Muliatama Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 308 M, volume 24 jam 27,5 rb), sedangkan Kian Santang Muliatama Tbk. diperdagangkan di Rp214 (kapitalisasi pasar 312,28 M, volume 24 jam 3,84 jt). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. dan Kian Santang Muliatama Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Kian Santang Muliatama Tbk. lebih aktif diperdagangkan (3,84 jt vs 27,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | RGAS | |
|---|---|---|
Kapitalisasi Pasar | 308 M | 312,28 M |
Volume | 27,5 rb | 3,84 jt |
Lot | 275 | 38,44 rb |
Perputaran | 6,23 jt | 812,79 jt |
Harga Rata-rata | 226,59 | 211,47 |
Nilai Transaksi | 6,23 jt | 812,79 jt |
Harga Ekuilibrium Indikatif | 230 | 214 |
Volume Ekuilibrium Indikatif | 110 | 179,1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Selengkapnya di halaman RGAS →